Skip to content

Clinical efficacy of self-adhesive silicone gel waterproof dressings versus conventional dressings in the healing of incisions after total joint arthroplasty: a prospective, randomized controlled trial study

Clinical efficacy of self-adhesive silicone gel waterproof dressings versus conventional dressings in the healing of incisions after total joint arthroplasty: a prospective, randomized controlled trial study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086947
Enrollment
Unknown
Registered
2024-07-15
Start date
2024-08-01
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Interventions

Self-adhesive silicone rubber waterproof dressing set:Self-adhesive silicone rubber waterproof dressing is used after artificial joint replacement surgery
Conventional sterile gauze dressing group:Conventional sterile gauze dressing is used after artificial joint replacement surgery

Sponsors

The first affliated hospital, Xinjiang medical university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Age =18 years old, gender is not limited; (2) Meet the diagnostic criteria for artificial joint replacement; (3) Initial joint replacement surgery; (4) Voluntary and signed informed consent.

Exclusion criteria

Exclusion criteria: (1) Allergic to self-adhesive silicone rubber waterproof dressing; (2) Patients with severe knee joint infection who cannot undergo artificial joint replacement; (3) Progressive renal insufficiency (stage 4 and above) or glomerular filtration rate less than 30ml/min; (4) periprosthesis infection after multiple joint replacement; (5) Active infection at the site of intravenous or joint injection; (6) long-term use of anticoagulants or antiplatelet drugs due to other diseases; (7) Have sepsis or positive blood culture within the last 30 days; (8) Radiotherapy and chemotherapy are required due to neoplastic diseases; (9) Receiving systemic glucocorticoid therapy (prednisone > 10mg/ day or equivalent hormone medication); (10) severe immunodeficiency diseases (such as stage 3 HIV, sickle cell anemia, splenectomy, etc.); (11) Have a history of drug abuse; (12) Treatment of bone marrow or other transplants with immunosuppressive drugs; (13) Pregnant, parturient and lactating women; (14) Participating in other clinical trials; (15) Researchers believe that other reasons are not appropriate for clinical trial participants.

Design outcomes

Primary

MeasureTime frame
Infection control rate; Rednes, Edema, Ecchymosis, Discharge, Approximation of wound edges score (REEDA);Manchester Scar Scale (MSS);

Secondary

MeasureTime frame
X-ray;American knee score (AKS score);Harris hip score (HHS score);Visual analogue scale score (VAS);Red blood routine ;liver function;kidney function;erythrocyte sedimentation rate (ESR);C-reactive protein (CRP);Re-operation rate;Doppler lower extremity vascular color ultrasound;

Countries

China

Contacts

Public ContactBoyong Xu

Department of Joint Surgery, The First Affiliated Hospital, Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region, People 's Republic of China

1031181455@qq.com+86 132 0126 3027

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026